ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 635922 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 635922; 2) Community: the network communities that were significantly associated with the response to NSC 635922; 3) Molecule: the relationships between components within communities and NSC 635922; 4) MDR: the compounds that were significantly associated with the NSC 635922.

NSC Compound Enrichment Correlation
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0278435641331424 0.47074312
NSC 30863 Null 0.0278435641331424 0.22027359
NSC 34533 Fulcin 0.0278435641331424 0.27573019
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0278435641331424 0.39059947
NSC 373355 Saframycin R 0.0278435641331424 0.23507783
NSC 48229 Null 0.0278435641331424 -0.19436912
NSC 529108 4-Fluoro-D,L-tryptophan 0.0278435641331424 0.44200602
NSC 610456 Camptothecin Derivative 0.0278435641331424 0.31200627
NSC 612223 Null 0.0278435641331424 0.38277974
NSC 617743 Pyridinium, 4-(4-methoxyphenyl)-1-(4-methylphenyl)- 2,6-diphenyl-, tetrafluoroborate(1-) 0.0278435641331424 0.1907417
Total:131  Current:92    [First] [Prev] [Next] [Last]